MUNGO, ELEONORA
MUNGO, ELEONORA
ONCOLOGIA
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
2019-01-01 Salaroglio I.C.; Mungo E.; Gazzano E.; Kopecka J.; Riganti C.
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells.
2018-01-01 Loredana Bergandi, Eleonora Mungo, Rosa Morone, Ornella Bosco, Barbara Rolando, Sophie Doublier
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer
2018-01-01 Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna
Klebsiella pneumoniae: emergence of multi-drug-resistant strains in Northwest Italy.
2012-01-01 Leone I.; Mungo E.; Bisignano G.; Chirillo M.G.; Savoia D.
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
2016-01-01 Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?
2020-01-01 Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells
2018-01-01 Mungo Eleonora, Bergandi Loredana, Salaroglio iris Chiara, Doublier Sophie
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer | 2019 | Salaroglio I.C.; Mungo E.; Gazzano E.; Kopecka J.; Riganti C. | |
Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells. | 2018 | Loredana Bergandi, Eleonora Mungo, Rosa Morone, Ornella Bosco, Barbara Rolando, Sophie Doublier | |
Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer | 2018 | Salaroglio, Iris C; Gazzano, Elena; Abdullrahman, Ahmad; Mungo, Eleonora; Castella, Barbara; Abd-Elrahman, Gamal Eldein Fathy Abd-Ellatef; Massaia, Massimo; Donadelli, Massimo; Rubinstein, Menachem; Riganti, Chiara; Kopecka, Joanna | |
Klebsiella pneumoniae: emergence of multi-drug-resistant strains in Northwest Italy. | 2012 | Leone I.; Mungo E.; Bisignano G.; Chirillo M.G.; Savoia D. | |
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma | 2016 | Buondonno, Ilaria; Gazzano, Elena; Jean, Sae Rin; Audrito, Valentina; Kopecka, Joanna; Fanelli, Marilù; Salaroglio, Iris C; Costamagna, Costanzo; Roato, Ilaria; Mungo, Eleonora; Hattinger, Claudia M; Deaglio, Silvia; Kelley, Shana O; Serra, Massimo; Riganti, Chiara | |
Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance? | 2020 | Kopecka J, Gazzano E, Castella B, Salaroglio IC, Mungo E, Massaia M, Riganti C | |
Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells | 2018 | Mungo Eleonora, Bergandi Loredana, Salaroglio iris Chiara, Doublier Sophie |